Teva To Buy U.s. Drug Developer Auspex Pharma For $3.5b

Deal boost its portfolio of treatments for the central nervous system.

BING NEWS:
  • Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal
    Vertex Pharmaceuticals will buy Alpine Immune Sciences for about $4.9 billion in cash, gaining access to the biotech firm's treatment for an autoimmune disease of the kidney, the companies said on ...
    04/10/2024 - 10:57 am | View Link
  • Teva and Viatris revive chance to dispute J&J's schizophrenia drug patent
    JNJ sued Mylan, now part of Viatris and Teva over patent infringement concerns for proposed generic versions of the drug in 2018 and 2019. In the 2021 ruling, U.S. District Judge Claire Cecchi ...
    04/1/2024 - 6:17 am | View Link
  • FTC weighs in on Teva's inhaler litigation against Amneal amid far-reaching patent crackdown
    When it comes to questioning drug patents, the U.S. Federal Trade Commission (FTC ... Teva, for its part, did not immediately respond to Fierce Pharma’s request for comment on the situation.
    03/24/2024 - 11:03 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News